Select Committee on China(@ChinaSelect):China’s growing role in pharmaceutical supply chains raises serious concerns. Recent reports of GLP-1 ingredients produced in bug-infested, mold-covered facilities underlines the risks of relying on a system with inadequate oversight. American patients should not pay the price of U.S. companies being dependent on Chinese drug manufacturing.

Select Committee on China

@ChinaSelect

Select Committee on China led by Chairman @RepMoolenaar

加入 January 2023

190 正在關注 64.9K 粉絲

Select Committee on China@ChinaSelect

2026.10.27 14:45

China’s growing role in pharmaceutical supply chains raises serious concerns. Recent reports of GLP-1 ingredients produced in bug-infested, mold-covered facilities underlines the risks of relying on a system with inadequate oversight. American patients should not pay the price of U.S. companies being dependent on Chinese drug manufacturing.